UBS AM’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.4M | Buy |
256,138
+55,442
| +28% | +$519K | ﹤0.01% | 2069 |
|
|
2025
Q1 | $2.47M | Buy |
200,696
+30,596
| +18% | +$376K | ﹤0.01% | 1889 |
|
|
2024
Q4 | $2.25M | Buy |
170,100
+32,653
| +24% | +$432K | ﹤0.01% | 1979 |
|
|
2024
Q3 | $2.65M | Sell |
137,447
-15,913
| -10% | -$306K | ﹤0.01% | 1897 |
|
|
2024
Q2 | $3.15M | Buy |
153,360
+56,527
| +58% | +$1.16M | ﹤0.01% | 1749 |
|
|
2024
Q1 | $2.3M | Buy |
96,833
+3,766
| +4% | +$89.6K | ﹤0.01% | 1621 |
|
|
2023
Q4 | $2.01M | Buy |
93,067
+16,404
| +21% | +$354K | ﹤0.01% | 1684 |
|
|
2023
Q3 | $1.11M | Buy |
76,663
+22,981
| +43% | +$334K | ﹤0.01% | 1903 |
|
|
2023
Q2 | $1.13M | Hold |
53,682
| – | – | ﹤0.01% | 1941 |
|
|
2023
Q1 | $1.13M | Sell |
53,682
-4,413
| -8% | -$93.2K | ﹤0.01% | 1941 |
|
|
2022
Q4 | $1.48M | Buy |
58,095
+14,792
| +34% | +$376K | ﹤0.01% | 1673 |
|
|
2022
Q3 | $1.04M | Sell |
43,303
-2,954
| -6% | -$71K | ﹤0.01% | 1942 |
|
|
2022
Q2 | $890K | Buy |
46,257
+7,385
| +19% | +$142K | ﹤0.01% | 2035 |
|
|
2022
Q1 | $676K | Hold |
38,872
| – | – | ﹤0.01% | 2342 |
|
|
2021
Q4 | $851K | Hold |
38,872
| – | – | ﹤0.01% | 2300 |
|
|
2021
Q3 | $743K | Sell |
38,872
-3,800
| -9% | -$72.6K | ﹤0.01% | 2310 |
|
|
2021
Q2 | $733K | Buy |
42,672
+4,285
| +11% | +$73.6K | ﹤0.01% | 2371 |
|
|
2021
Q1 | $858K | Buy |
38,387
+12,187
| +47% | +$273K | ﹤0.01% | 2161 |
|
|
2020
Q4 | $583K | Buy |
+26,200
| New | +$583K | ﹤0.01% | 2248 |
|